BIOMAT Database Logo BIOMAT Database Logo

Protein kinase C and amyloid precursor protein processing in skin fibroblasts from sporadic and familial Alzheimer's disease cases. 1999

M Vestling, and A Cedazo-Mínguez, and A Adem, and B Wiehager, and M Racchi, and L Lannfelt, and R F Cowburn
Division of Geriatric Medicine, Karolinska Institute, Novum, KFC, Plan 4, S-141 86, Huddinge, Sweden.

Non-amyloidogenic alpha-secretase processing of amyloid precursor protein (APP) is stimulated by protein kinase C (PKC). Levels and activity of PKC are decreased in sporadic Alzheimer's disease skin fibroblasts. We investigated whether alterations in PKC and PKC-mediated APP processing occur also in fibroblasts established from individuals with familial Alzheimer's disease APP KM670/671NL, PS1 M146V and H163Y mutations. These pathogenic mutations are known to alter APP metabolism to increase Abeta. PKC activities, but not levels, were decreased by 50% in soluble fractions from sporadic Alzheimer's disease cases. In contrast, familial Alzheimer's disease fibroblasts showed no significant changes in PKC enzyme activity. Fibroblasts bearing the APP KM670/671NL mutation showed no significant differences in either PKC levels or PKC-mediated soluble APP (APPs) secretion, compared to controls. Fibroblasts bearing PS1 M146V and H163Y mutations showed a 30% increase in soluble PKC levels and a 40% decrease in PKC-mediated APPs secretion. These results indicate that PKC deficits are unlikely to contribute to increased Abeta seen with APP and PS1 mutations, and also that PS1 mutations decrease alpha-secretase derived APPs production independently of altered PKC activity.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010450 Endopeptidases A subclass of PEPTIDE HYDROLASES that catalyze the internal cleavage of PEPTIDES or PROTEINS. Endopeptidase,Peptide Peptidohydrolases
D011493 Protein Kinase C An serine-threonine protein kinase that requires the presence of physiological concentrations of CALCIUM and membrane PHOSPHOLIPIDS. The additional presence of DIACYLGLYCEROLS markedly increases its sensitivity to both calcium and phospholipids. The sensitivity of the enzyme can also be increased by PHORBOL ESTERS and it is believed that protein kinase C is the receptor protein of tumor-promoting phorbol esters. Calcium Phospholipid-Dependent Protein Kinase,Calcium-Activated Phospholipid-Dependent Kinase,PKC Serine-Threonine Kinase,Phospholipid-Sensitive Calcium-Dependent Protein Kinase,Protein Kinase M,Calcium Activated Phospholipid Dependent Kinase,Calcium Phospholipid Dependent Protein Kinase,PKC Serine Threonine Kinase,Phospholipid Sensitive Calcium Dependent Protein Kinase,Phospholipid-Dependent Kinase, Calcium-Activated,Serine-Threonine Kinase, PKC
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003470 Culture Media Any liquid or solid preparation made specifically for the growth, storage, or transport of microorganisms or other types of cells. The variety of media that exist allow for the culturing of specific microorganisms and cell types, such as differential media, selective media, test media, and defined media. Solid media consist of liquid media that have been solidified with an agent such as AGAR or GELATIN. Media, Culture
D005260 Female Females
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M Vestling, and A Cedazo-Mínguez, and A Adem, and B Wiehager, and M Racchi, and L Lannfelt, and R F Cowburn
Reduced protein kinase C activity in sporadic Alzheimer's disease fibroblasts.
November 1991, Neuroscience letters,
M Vestling, and A Cedazo-Mínguez, and A Adem, and B Wiehager, and M Racchi, and L Lannfelt, and R F Cowburn
Bradykinin-induced amyloid precursor protein secretion: a protein kinase C-independent mechanism that is not altered in fibroblasts from patients with sporadic Alzheimer's disease.
March 1998, The Biochemical journal,
M Vestling, and A Cedazo-Mínguez, and A Adem, and B Wiehager, and M Racchi, and L Lannfelt, and R F Cowburn
Amyloid precursor protein processing and Alzheimer's disease.
January 2011, Annual review of neuroscience,
M Vestling, and A Cedazo-Mínguez, and A Adem, and B Wiehager, and M Racchi, and L Lannfelt, and R F Cowburn
Molecular pathology of Alzheimer's disease in sporadic and familial Alzheimer's disease with mutations in the amyloid precursor protein.
August 1992, Biochemical Society transactions,
M Vestling, and A Cedazo-Mínguez, and A Adem, and B Wiehager, and M Racchi, and L Lannfelt, and R F Cowburn
Defective protein kinase C alpha leads to impaired secretion of soluble beta-amyloid precursor protein from Alzheimer's disease fibroblasts.
January 1996, Annals of the New York Academy of Sciences,
M Vestling, and A Cedazo-Mínguez, and A Adem, and B Wiehager, and M Racchi, and L Lannfelt, and R F Cowburn
Processing and secretion of Alzheimer's disease amyloid precursor protein.
November 1994, The Tohoku journal of experimental medicine,
M Vestling, and A Cedazo-Mínguez, and A Adem, and B Wiehager, and M Racchi, and L Lannfelt, and R F Cowburn
Abnormal and deficient processing of beta-amyloid precursor protein in familial Alzheimer's disease lymphoblastoid cells.
March 1991, Biochemical and biophysical research communications,
M Vestling, and A Cedazo-Mínguez, and A Adem, and B Wiehager, and M Racchi, and L Lannfelt, and R F Cowburn
Familial Alzheimer's disease with the amyloid precursor protein position 717 mutation and sporadic Alzheimer's disease have the same cytoskeletal pathology.
March 1992, Neuroscience letters,
M Vestling, and A Cedazo-Mínguez, and A Adem, and B Wiehager, and M Racchi, and L Lannfelt, and R F Cowburn
Processing of Mutant β-Amyloid Precursor Protein and the Clinicopathological Features of Familial Alzheimer's Disease.
April 2019, Aging and disease,
M Vestling, and A Cedazo-Mínguez, and A Adem, and B Wiehager, and M Racchi, and L Lannfelt, and R F Cowburn
Processing of Alzheimer's disease-associated beta-amyloid precursor protein.
January 1990, Journal of molecular neuroscience : MN,
Copied contents to your clipboard!